In line with these findings, a study by Nagdas et al. indicated that DRP1 was required for the KRas-driven anchorage-independent growth in fibroblasts and patient-derived pancreatic cancer cell lines, promoting glycolysis flux [61]. Here, KRAS is linked to pancreatic neoplasm.